INTRODUCTION
============

Wound healing is a complex process involving soluble mediators, blood cells, extracellular matrix, and parenchymal cells ([@B60]; [@B8]; [@B49]). The process from inflammation to the wound healing is divided into three phases: (1) inflammation process, (2) tissue formation, and (3) tissue remodeling (**Figure [1](#F1){ref-type="fig"}**; [@B25]). The inflammatory phase is marked by platelet accumulation, coagulation, and leukocyte migration. The tissue formation is characterized by re-epithelialization, angiogenesis, fibroplasia, and wound contraction. Finally, the remodeling phase takes place over a period of months, during which the dermis responds to injury with the production of collagen and matrix proteins and then returns to its pre-injury phenotype ([@B34]; [@B12]; [@B3]). The normal healing response begins the moment the tissue is injured. Peripheral blood components filtrated into the site of injury, the platelets contact with exposed collagen and other elements of the extracellular matrix through the process from inflammation to wound healing ([@B19]). This contact triggers the platelets to release clotting factors as well as essential growth factors and cytokines such as platelet-derived growth factor (PDGF), such as stimulation of DNA synthesis and chemotaxis of fibroblasts moreover smooth muscle cells to induce the production of collagen, glycosaminoglycan, and collagenase by fibroblasts through the wound healing process ([@B39]; [@B51]; [@B64]). Furthermore, PDGF appears to transduce its signal through wound macrophages and may trigger the activation of feedback loops and synthesis of endogenous wound PDGF and other growth factors, thereby enhancing the cascade of tissue repair processes required for a fully healed wound ([@B50]). In a normal response to injury, platelet aggregation and degranulation of the earliest events in an inflammatory response trigger the release of numerous inflammatory mediators including transforming growth factor-β (TGF-β) from the granules ([@B65]; [@B63]; [@B14]). TGF-β is implicated in pathogenic fibrotic conditions in kidney, liver, and lung disease, and in scarring of skin wounds as well ([@B41]; [@B58]). Accumulating evidence indicates that TGF-β affects integrin-mediated cell adhesion and migration by regulating the expression of integrins, their ligands and integrin-associated proteins ([@B40]). Research indicated that a synthetic TGF-β is effective in accelerating wound healing and reducing scarring in pig skin burn, pig skin excision, and rabbit skin excision injury models ([@B32]).

![**The process from inflammation to the wound healing is divided into three phases: (1) Inflammation process, (2) tissue formation, and (3) tissue remodeling.** The important question, "what is the key linkage between the tissue formation and inflammation?"](fphar-05-00001-g001){#F1}

INFLAMMATION PROCESS
====================

Inflammation is known to be a crucial adaptive response for animals, and the mechanism is a complex interaction with molecular mediators even the functions of immune cells in a microenvironment through a response that occurs at all levels of biological organization ([@B2]). In this process, cooperation among cells and mediators occurs, and a wide range of factors are involved in the classical immune response, including the stage of the inflammation process; the tissue or organ involved; and whether the inflammation is acute and resolving or chronic and non-resolving ([@B52]). The inflammation process involves vascular permeability, active migration of blood cells, and the passage of plasma constituents into injurious tissue ([@B42]). Through the infiltration of immune cells, studies have shown that the inflammation process plays a crucial role in atherosclerosis ([@B56]). Blood leukocytes, mediators of host defenses and inflammation, localize in the earliest lesions of atherosclerosis in experimental animals. The study of inflammation in atherosclerosis has afforded considerable new insight into the mechanisms underlying the recruitment of leukocytes ([@B38]). Recently, studies have indicated the role of inflammation in Alzheimer's disease (AD; [@B57]). Inflammatory components related to AD neuroinflammation include brain cells, such as microglia and astrocytes, the complement system, and cytokines and chemokines ([@B53]). Regarding cancer development ([@B29]), pro-inflammatory cytokines, including interleukin (IL)-1α, IL-1β, IL-6, IL-8, IL-18, chemokines, matrix metallopeptidase (MMP)-9, and vascular endothelial growth factor (VEGF) are primarily regulated by the transcription factor nuclear factor (NF)-kB, which is active in most tumors and is induced by carcinogens ([@B1]). Cutaneous wound repair is a tightly regulated and dynamic process involving blood clotting, inflammation, formation of new tissue, and tissue remodeling ([@B45]). Thrombin is the protease involved in blood coagulation. Its deregulation can lead to hemostatic abnormalities, which range from subtle subclinical to serious life-threatening coagulopathies, i.e., during septicemia ([@B15]). Inflammation and blood coagulation are the part of the innate host protection mechanism on vascular injury, infection or other wound. Not only the cell of the innate immune system but also activated endothelial cells and platelets are actively involved in acute and chronic inflammation: they release of pro-inflammatory mediators, expose adhesion molecules and receptors, proteases and its inhibitors, clotting factors and associated proteins, and recruit leukocytes ([@B61]). In the process, PAR family serve as sensors of serine proteinases of the blood clotting system in the target cells involved in inflammation. Activation of PAR-1 by thrombin and of PAR-2 by factor leads to a rapid expression and exposure on the membrane of endothelial cells of both adhesive proteins that mediate an acute inflammatory reaction and of the tissue factor that initiates the blood coagulation cascade.([@B22]).

MEDIATORS OF INFLAMMATION
=========================

In the inflammation, microenvironment is related to cellular trans-differentiation, migration, proliferation, survival, and extracellular matrix formation. The growth factors likely to be involved are PDGF, TNF-α and TNF-β, HGF, TGF-β2, epidermal growth factor (EGF), and fibroblast growth factor (FGF). Cytokines such as IL-1, IL-6, IL-8, IL-10, and interferon gamma (INF-γ) are also thought to play a role ([@B44]). It is clearly a balance between appropriate fibroblast activation and the fibrosis that results from their continuing activation. Multiple growth factors have been implicated in fibroblast migration and activation, but much attention has been recently focused on the PDGF family of growth factors and their cognate receptors (PDGFRs; [@B46]). Research has documented that PDGF exerts autocrine, mitogenic effect on keratinocytes to support epidermal proliferation and stabilization of the dermoepidermal junction during wound closure. In addition, it stimulates vessel maturation by recruitment and differentiation of pericytes to the immature-endothelial channels ([@B30]).

Studies have investigated the cytokines involved in the inflammation response by using various animal models. The expression of pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNF)-α, is significantly increased in the adipocytes of obese animals (ob/ob mouse, db/db mouse, and fa/fa Zucker rat; [@B31]). The activation of TNF-α might induce leukocytes express adhesion molecules on the cell surface ([@B23]; [@B7]; [@B35]), leading to diapedesis through individual vascular endothelial cells ([@B10]). IL-6 is an adipokine ([@B26]) thought to be a mediator of inflammation ([@B68]; [@B16]; [@B62]) that is produced by adipose tissue and liver-resident macrophages that are activated in response to hepatocyte death ([@B54]). IL-6-deficient mice exhibit a marked decrease in inflammatory response, granulation tissue formation, and re-epithelialization ([@B28]). The IL-1 family, which includes IL-1α and IL-1β, exhibits strong pro-inflammatory activities and plays a major role in host responses to exogenous and endogenous noxious stimuli ([@B27]). IL-1 induces the expression of adhesion molecules on endothelial cells and elicits stromal cells to release chemokines that promote the recruitment of inflammatory cells at the inflammation site ([@B20]; [@B13]; [@B33]). Such inflammation occurs significantly in cases of comorbidity and might contribute to the increased risk of developing cardiovascular accidents observed in these patients ([@B11]). IL-10, a cytokine with anti-inflammatory properties, plays a central role in infection that involves limiting the immune response to pathogens and thereby preventing damage to the host ([@B55]). Recently, research has shown that IL-10 and related cytokines can facilitate the tissue-healing process in injuries caused by infection or inflammation ([@B47]). According to these studies, mediators thought to be involved in the regulation of inflammation responses such as leukocyte recruitment, adhesion molecule expression, and wound healing in the late phase of inflammation.

IMMUNE CELL-WOUND HEALING
=========================

Immune cells are involved in virtually every aspect of the wound repair process, from the initial stages where they participate in hemostasis and work to prevent infection to later stages where they drive scar formation ([@B66]). Evidence supporting a central role for T lymphocytes in the control of wound healing is provided by studies which examine the *in vivo* effects of alternate forms of T cell manipulation on various parameters of healing ([@B4]) and Neutrophils as important to wound healing as they help control infection, however, they also release harmful enzymes which damage healthy tissue surrounding the wound site ([@B6]). Investigations have enumerated many of the specific proteins that are produced by wound macrophages at the site of injury. These include the following: (1) chemoattractants that recruit and activate additional macrophages at the site of injury, (2) growth factors that promote cellular proliferation and protein synthesis, (3) proteases and extra-cellular matrix molecules, and (4) factors that may restrain tissue growth once repair is completed ([@B21]). Neutrophils arrive first within a few minutes, followed by monocytes and lymphocytes. They produce a wide variety of proteinases and reactive oxygen species as a defense against contaminating microorganisms, and they are involved in the phagocytosis of cell debris. Neutrophil play a role as primarily phagocytosis appearing approximately 24 h after injury and contribute to decreasing the infection in the wound. Neutrophils are not paramount to the process of wound healing or collagen synthesis ([@B48]). Research has been shown a role of neutrophil in wound healing for the production of neutrophil growth factors, such as granulocyte/macrophage colony-stimulating factor (GM-CSF; [@B9]). Experiments with cultures of keratinocytes established from ^-/-^ and ^+/+^ mice revealed a retardation in wound closure in CXCR2 ^-/-^keratinocytes, role for this receptor on keratinocytes in epithelial resurfacing that is independent of neutrophil recruitment ([@B18]). In the resolution and regeneration stages, macrophages appear to remove large cell debris as well as apoptotic neutrophils, the key scavengers for resolving inflammation and facilitating tissue regrowth, furthermore, experiment illustrated that the depletion of macrophages in zebrafish model leads to the delay of the clearance of cell debris, decrease of regeneration speed, and formation of vacuoles in the regenerating fin ([@B37]). Recently, research has shown that wound healing requires a coordinated interplay among cells, growth factors, and extracellular matrix proteins. Central to this process is the endogenous mesenchymal stem cell (MSC), which coordinates the repair response by recruiting other host cells and secreting growth factors and matrix proteins. MSCs are self-renewing multipotent stem cells that can differentiate into various lineages of mesenchymal origin such as bone, cartilage, tendon, and fat ([@B43]).

APOPTOTIC CELL-WOUND HEALING
============================

Evidence illustrated that apoptosis is involved in the resolution of various phases of tissue repair. In the early phases of tissue repair, inflammatory cells underwent apoptosis starting as early as 12 h after wound injured ([@B5]). Examined apoptotic patterns in cells in open wounds created in rats, found that apoptosis marked observed in the inflammatory cells of the scab. In this research found that apoptosis in myofibroblasts initiated on day 12, peaked at day 20, and resolved at day 60. These findings suggest that myofibroblast apoptosis initiated about the same time at the end of the wound following to the healing ([@B17]). Stromal keratocyte apoptosis has been well-characterized as an early initiating event of the corneal wound healing response, triggering subsequent cellular processes that include bone marrow-derived cell infiltration, proliferation, and migration of residual keratocyte cells, and, in some circumstances, generation of myofibroblast cells ([@B67]). Impaired phagocytosis of apoptotic neutrophils by Vav3^-/-^ (guanine-nucleotide exchange factors implicated in leukocyte functions by relaying signals from immune response receptors and integrins to Rho-GTPases) macrophages was causal for their reduced release of active TGF-β1, for decreased myofibroblasts differentiation and myofibroblast-driven wound contraction to cause the situation of delayed wound healing ([@B59]). Apoptotic cells released growth signals that stimulated the proliferation of progenitor or stem cells by caspases 3 and 7 proteases which involves the caspase-mediated activation of phospholipase A2 and the subsequent production and release of the lipid signal prostaglandin E2, a stimulator of cell proliferation and mice lacking either of these caspases were deficient in skin wound healing ([@B36]). We thought the inflammation factors that may be also involved in the followed healing process. But the question is "what kind of factor is the major key involved in the end of the inflammation then to initiate the healing." We suspect that the apoptosis of immune cell may be the major key to end of inflammation and to initiate the healing as shown in **Figure [2](#F2){ref-type="fig"}**.

![**Apoptotic immune cell linkage wound healing.** When tissues are damaged, inflammatory mediators are released. Where macrophages and become activated by various cytokines, such as interferon-γ (IFN-γ), that are released from neighboring inflammatory cells, including neutrophils, natural killer (NK) cells, resident tissue macrophages, and T cells. In the end of the inflammation, we can observe the apoptosis of the immune cells and the apoptotic cells cleared by macrophages. We thought that clearance by macrophages of cells apoptosis is a key point phenomenon associated with actively tissue formation from wound inflammation. The apoptotic immune may drive the conversion of the immune response into a wound healing response, which is characterized by the accumulation of macrophages that promote wound healing and fibrosis through the production of MMPs (including MMP12, tissue inhibitor of metalloproteinases 1 (TIMPs1), growth factors \[including platelet-derived growth factor (PDGF)\], and cytokines \[such as transforming growth factor-β1 (TGF-β1)\].](fphar-05-00001-g002){#F2}

CONCLUSION
==========

We hypothesized that the key point to end of the inflammation is the apoptotic activity of immune cells. Apoptosis is considered a vital component of various processes including normal cell turnover, proper development and functioning of the immune system, hormone-dependent atrophy, embryonic development, and chemical-induced cell death ([@B24]). In the inflammation response, the mediators induce the infiltration of activated immune cells into inflammation site to protect the tissue against the pathogen infection. In the end of the inflammation, we can observe the apoptosis of the immune cells and the apoptotic cells cleared by macrophages. We thought that clearance by macrophages of cells apoptosis is a key point phenomenon associated with actively tissue formation from wound inflammation.
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